[{"Assets_0_Q3_USD":8769100000.0,"CIK":"1596783","CommonStockSharesConverted_0_Q3_shares":170133258.0,"CommonStockSharesOutstanding_0_Q3_shares":170133258.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":1.27,"EarningsPerShareBasic_3_Q3_USD":2.15,"EarningsPerShareDiluted_1_Q3_USD":1.26,"EarningsPerShareDiluted_3_Q3_USD":2.12,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"17076283108.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":298700000.0,"NetIncomeLossConverted_1_Q3_USD":231800000.0,"NetIncomeLossConverted_3_Q3_USD":402600000.0,"OfficialName":"Catalent Inc. Common Stock","RevenuesConverted_1_Q3_USD":1053300000.0,"RevenuesConverted_3_Q3_USD":2809800000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":3713200000.0,"StockholdersEquity_0_Q3_USD":3713200000.0,"Ticker":"CTLT","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":172500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":169500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":170500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":167200000.0,"filed":"20210504","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2021.0","name":"CATALENT, INC.","period":"20210331","qtrs":"1","uom":"USD"}]